Ignite Creation Date:
2025-12-25 @ 2:29 AM
Ignite Modification Date:
2026-01-08 @ 12:42 AM
Study NCT ID:
NCT03345134
Status:
NOT_YET_RECRUITING
Last Update Posted:
2017-11-17
First Post:
2017-11-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pembrolizumab in Combination With BCG After Ablation in Patients With UUTTCC Without Nephroureterectomy
Sponsor:
Shaheen Alanee
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-11-30
Start Date Type:
ESTIMATED
Primary Completion Date:
2021-01-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2021-01-01
Completion Date Type:
ESTIMATED
First Submit Date:
2017-11-03
First Submit QC Date:
None
Study First Post Date:
2017-11-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-11-13
Last Update Post Date:
2017-11-17
Last Update Post Date Type:
ACTUAL